Yesterday, the EMA announced the Open Call for applications for new data partners to support real-world data evaluation through DARWIN EU. Additionally, three studies have been completed evaluating prevalence of rare hematological cancers, use of valproate and antibiotics. A fourth study evaluating serious adverse events in asthma is still ongoing.
Background on HMA-EMA’s joint Big Data Initiative
The Big Data Task Force initially provided 10 priority recommendations for developing competencies and uses for big data.
Fill out the form to read the full article.
